Clinical Trials Logo
  1. Home
  2. Hepatitis D, Chronic
  3. NCT02731131

A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

Hepatitis D, Chronic Clinical Trial

Official title:
A Randomized, Pilot, Open-Label, Monocenter, Efficacy and Safety Study Examining the Effects of Peginterferon Alfa-2a (Pegasys) With or Without Ribavirin (Copegus) in Patients With Chronic Hepatitis D

Clinical Trial Summary

This single-center, randomized, open-label, pilot study is designed to evaluate the efficacy and safety of 48 weeks of treatment with peginterferon alfa-2a alone versus in combination with ribavirin in participants with CHD.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02731131
Study type Interventional
Source Hoffmann-La Roche
Contact
Status Completed
Phase Phase 2
Start date October 2004
Completion date March 2010
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05461170 - SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. Phase 2
Active, not recruiting NCT04535544 - A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus Phase 2
Completed NCT02732639 - A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) Phase 3
Completed NCT02765802 - A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection Phase 2
Active, not recruiting NCT05229991 - Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection Phase 3
Terminated NCT01861444 - An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) N/A
Active, not recruiting NCT03105310 - Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D Phase 2
Recruiting NCT04166266 - Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
Completed NCT01088659 - A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. Phase 3
Completed NCT00686790 - Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) Phase 3
Completed NCT02876419 - A Long Term Follow-up Study of Patients From the REP 301 Protocol